Dec 10, 2019 | 2019, 2019 Education Program, 2019 Scientific Program, 2019 Special-Interest Sessions, 2019 Tuesday
By Janice Staber, MD There have been years when the hemostasis and thrombosis community might have felt a little left behind at the ASH annual meeting. However, here in Orlando, sessions on hemostasis and thrombosis were discussed front and center. From the...
Dec 10, 2019 | 2019, 2019 Scientific Program, 2019 Spotlight Sessions, 2019 Tuesday
By Lynn Malec, MD, MSc, and Janice Staber, MD From the stock market to politics, keeping gains and losses straight these days can be confusing. Scientific gains and losses can be equally overwhelming. Thankfully, in Monday’s Scientific Spotlight Session on Redox...
Dec 9, 2019 | 2019 Monday, 2019 Scientific Program
By Lynn Malec, MD, MSc, and Janice Staber, MD When one hematologic disorder begets another, unlocking the mystery of the mechanisms of disease is the first crucial step in identifying potential targets for future therapeutic modulation. It is known that hemolytic...
Dec 8, 2019 | 2019 Scientific Program, 2019 Sunday
By Basem M. William, MD, MRCP(UK), FACP Donnall Thomas, MD, pioneered the first successful allogeneic bone marrow (BM) trans- plant, and reported on it in the New England Journal of Medicine in 1957, extending hope to many patients with incurable hematologic...
Dec 8, 2019 | 2019 Scientific Program, 2019 Sunday
By Binod Dhakal, MD, MS In 1951 a renowned hematologist from Harvard University, William Dameshek, MD, wrote an editorial in Blood providing seminal insight into myeloproliferative neoplasms (MPNs) — a group of disorders characterized by expansion of different myeloid...
Dec 8, 2019 | 2019 Scientific Program, 2019 Sunday
Continuing Conversations with the Speakers sessions allow for informal discussions with Scientific Program session speakers that will give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic...
